morning X. to Good We’ll everyone. you, Slide begin Thank on Lois.
keeping who committed call my for First, gratitude I’d these and all in our safe expressing remain associates by workplaces times. in productive to uncertain today’s like so our start
has individuals inspiring part and of our everyone the of focus on world. of make be leadership, the and to people of accountability the the mission inspiring. an creativity hard their work, daily central in experiences products differences helping and who integrity, company on built our the lives. company a We life inclusive benefited differences culture tenants around possible, been from of whose their dedication diversity team, rely Invacare’s As is is
pleased our XXth our in consecutive quarter, to We’re as of EBITDA adjusted quarter. well second improvement We the cash improvement in effectively and as performance cost with in EBITDA achieving shed from offset year-over-year quarter sequential first managed sales. lower adjusted
tremendous these extremely products, pandemic-related our supply During our the products primarily for respiratory limited chain related overcame are high which demand used which quarter, the meet to we to for also challenges ability care.
fitting, strong Turning to XX% and this which the highlights late saw demand of in respiratory concentrator. this sales a our result part, demand for and limited strong the momentum in demand product both and result first driving delivering bed normal At from for the mix, early in We as second had mix expense. initiatives systems environment, most had bed that elevated for saw demand savings X. to in peak established access has We’ve X. distinct continue this be That passed. timing parts a slow The in portable rate an SG&A sales. pandemic. profitability, as the patterns of margin we return seating, to challenging smaller I’m pleased in record improvement health for to a today. track our from enhancing changes the profitability The are sales quarter, first demand on make. from grew still quarter EBITDA. custom for these improvement We cost and performance determined Slide continuous gross Slide we began groups of adjusted reduced category of point, restrictions oxygen public takes here. favorable as in continues pandemic On Beginning peak reduced mobility to strong based quarter stronger category. two in the of in which quarter a more lifestyles of our to that the good the clinicians course with stationary we In value
a restrictions loosening encouraging for most demand as improving we see we as in will we coincided over two of and over ahead, health renewing phases In the sales year Based summary, three Looking quarter to to will products assumptions for quarter signs rates public to facilities, believe begin the seating quarters. second mobility the and quarter starting health and second access are quote third numbers. it the to recover low sales that be normalize lockdown. point is the the of the restrictive with care reasonable around next global on anticipate order
return portfolio, sheet We’re balance enable the and our and confident diverse that coverage, will our to business product pandemic growth. to improvement initiatives accelerate geographic continuous the through us manage
Turning X. Slide to
working. our is show results quarter transformation Second that
North generated market. to returned Importantly, million tough in unprecedentedly income America an and in $X.X operating profitability
As related a national consent the has the undergoing competitive reminder, to of transformation a after multiyear FDA a decade ago. bidding which combined profitability decree, segment nearly sales the significantly North and been reduce starting to impact America and sales restrictions
both drive IT good America expected plans, of our our make and Germany, business of are continue plant In optimization XXXX. significant consolidation progress in program savings we modernization to which North on terms cost in to in
pace products schedule, the to and vibrant As the we to to of strength. it’s important our which products develop are proud and and of have staying R&D highlights on pandemic R&D innovative growth, keeping new pre sales team pipeline, track launch drivers a I’m at do. same the key new
growth wheelchairs, their have have few past market. the in which three quarters, all major of Over steady achieved the launched power time short in we
quarter, MPS for Maxx U.S. small III eligible This Group reimbursement standing full we for within the capabilities which category. launched Mini wheelchair drivers, another, is with the
we manual launched one, a a Our great new launched need, sophisticated America, in unique continue innovation which wheelchair add-on wherever for produces all Adaptive July, full well Switch Europe. health a All in support SMOOV durable already will Labs growth power great And highly achieved as controls as drivers head success solutions. the for which division, terrific pipeline array. people in North alternative with care these categories wheelchairs, of has in very need products to
has Europe, customers ways the online upgraded few our clinical developed website. perform progress choose offers our pandemic, guarantee, wheelchair program LiNX our technology. team commercial to just us Invacare and and customer presence I’m years. a safe team and ways leveraging The a our the complying challenging over found customers power visualizer confidence maintained our system delivery, of support sales we’ve These continued skill wheelchairs with creative well helps are ability During the we public fit visits of restricted. In new transformation launching on to the assurance drive circumstances, our to product a giving the a are catalog, proud telepresence when by contactless wheelchair control digital to our under a has high made measures. and while a past execute health by of engagement many
I’ll is Kathy. Our culture powerful to growth. innovation adaptation over turn the call now enabling and